| Name | 5-Bromo-2-ethoxypyridine |
|---|---|
| Synonyms |
MFCD00234311
Pyridine, 5-bromo-2-ethoxy- 3-bromo-6-ethoxy-pyridine 5-Bromo-2-ethoxypyridine 2-ethoxy-5-bromo-pyridine 5-bromo-2-ethoxy-pyridine |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 216.3±20.0 °C at 760 mmHg |
| Melting Point | 32-36ºC |
| Molecular Formula | C7H8BrNO |
| Molecular Weight | 202.048 |
| Flash Point | 84.6±21.8 °C |
| Exact Mass | 200.978912 |
| PSA | 22.12000 |
| LogP | 3.14 |
| Vapour Pressure | 0.2±0.4 mmHg at 25°C |
| Index of Refraction | 1.534 |
| Symbol |
GHS05, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H302-H315-H317-H318-H335 |
| Precautionary Statements | P261-P280-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R22;R37/38;R41 |
| Safety Phrases | S26-S36/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2933399090 |
|
~96%
55849-30-4 |
| Literature: PROGENICS PHARMACEUTICALS, INC. Patent: WO2009/155527 A2, 2009 ; Location in patent: Page/Page column 127 ; WO 2009/155527 A2 |
|
~89%
55849-30-4 |
| Literature: PFIZER PRODUCTS INC. Patent: WO2006/106416 A1, 2006 ; Location in patent: Page/Page column 36 ; WO 2006/106416 A1 |
|
~%
55849-30-4 |
| Literature: US2002/37889 A1, ; |
|
~39%
55849-30-4 |
| Literature: Anderson, Erin D.; Boger, Dale L. Journal of the American Chemical Society, 2011 , vol. 133, # 31 p. 12285 - 12292 |
|
~%
55849-30-4 |
| Literature: Yakugaku Zasshi, , vol. 72, p. 381 Chem.Abstr., , p. 6403 Recueil des Travaux Chimiques des Pays-Bas, , vol. 68, p. 275,282 |
|
~%
55849-30-4 |
| Literature: Recueil des Travaux Chimiques des Pays-Bas, , vol. 69, p. 673,690 |
|
~%
55849-30-4 |
| Literature: Yakugaku Zasshi, , vol. 72, p. 381 Chem.Abstr., , p. 6403 Recueil des Travaux Chimiques des Pays-Bas, , vol. 68, p. 275,282 |
| Precursor 8 | |
|---|---|
| DownStream 3 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |